Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC152274 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KREMEN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101928417 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFAP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GML - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SLC26A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDH8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDH11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRZB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00642 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GHSR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CILP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRG2EP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on